-+ 0.00%
-+ 0.00%
-+ 0.00%

AZITRA, INC. ADVANCES ATR-04 PHASE 1/2 CLINICAL TRIAL TO COHORT 2 FOLLOWING SAFETY REVIEW COMMITTEE CLEARANCE

Reuters·10/01/2026 12:00:10

Please log in to view news